These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 15050083

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. HIV-infected i.v. drug users in methadone treatment: outcome and psychological correlates--a preliminary report.
    Batki SL, Sorensen JL, Gibson DR, Maude-Griffin P.
    NIDA Res Monogr; 1989; 95():405-6. PubMed ID: 2641010
    [No Abstract] [Full Text] [Related]

  • 25. Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group.
    Reynaud-Maurupt C, Carrieri MP, Gastaud JA, Pradier C, Obadia Y, Moatti JP.
    AIDS Care; 2000 Aug; 12(4):461-70. PubMed ID: 11091779
    [Abstract] [Full Text] [Related]

  • 26. Sexual behaviors and HIV infection in intravenous drug users in New York City.
    Banks SE, Brown LS, Ajuluchukwu D.
    J Addict Dis; 1991 Aug; 10(3):15-23. PubMed ID: 1932149
    [Abstract] [Full Text] [Related]

  • 27. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP, Balthasar H, Huissoud T, Jeannin A, Dubois-Arber F.
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [Abstract] [Full Text] [Related]

  • 28. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M, Amsterdam Cohort.
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [Abstract] [Full Text] [Related]

  • 29. Effects of changes in perceived self-efficacy on HIV risk behaviors over time.
    Kang SY, Deren S, Andia J, Colón HM, Robles R.
    Addict Behav; 2004 May; 29(3):567-74. PubMed ID: 15050674
    [Abstract] [Full Text] [Related]

  • 30. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

  • 31. Brief motivational intervention to reduce HIV risk and to increase HIV testing among offenders under community supervision.
    Alemagno SA, Stephens RC, Stephens P, Shaffer-King P, White P.
    J Correct Health Care; 2009 Jul 15; 15(3):210-21. PubMed ID: 19477803
    [Abstract] [Full Text] [Related]

  • 32. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R, Ingram J, Rees A, Neale J, Beattie A, Telfer M.
    Subst Abuse Treat Prev Policy; 2014 Nov 18; 9():44. PubMed ID: 25407020
    [Abstract] [Full Text] [Related]

  • 33. [Impact of methadone maintenance treatment on HIV risk behaviors of heroin drug users].
    Liu EW, Liang T, Shen LM, Zhong H, Wang B, Wu ZY, Detels R.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Nov 18; 44(11):981-4. PubMed ID: 21215123
    [Abstract] [Full Text] [Related]

  • 34. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T, Marsh D, Li K, Montaner J, Wood E.
    Drug Alcohol Depend; 2005 Dec 12; 80(3):329-35. PubMed ID: 15964714
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    Garfein RS, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, Kapadia F, Latka MH, Ouellet LJ, Purcell DW, Strathdee SA, Thiede H, DUIT Study Team.
    AIDS; 2007 Sep 12; 21(14):1923-32. PubMed ID: 17721100
    [Abstract] [Full Text] [Related]

  • 37. Heroin dependence and bloodborne virus transmission behaviors for HIV infection among newly incarcerated injection drug users in Taiwan.
    Ko NY, Hsu ST, Chen CH, Lee HC, Ko WC.
    Subst Use Misuse; 2011 Sep 12; 46(5):591-8. PubMed ID: 20964533
    [Abstract] [Full Text] [Related]

  • 38. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J, Verthein U, Karow A, Schäfer I, Naber D, Haasen C.
    Addiction; 2011 Sep 12; 106(9):1647-55. PubMed ID: 21489005
    [Abstract] [Full Text] [Related]

  • 39. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Torian LV, Friedman SR.
    AIDS; 2007 Jan 11; 21(2):231-5. PubMed ID: 17197815
    [Abstract] [Full Text] [Related]

  • 40. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM, Conigrave KM.
    Drug Alcohol Rev; 2007 Jul 11; 26(4):445-54. PubMed ID: 17564883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.